Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / HEALTHCARE BUL
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
59,622
-
Shares change
-
+32,967
-
Total reported value, excl. options
-
$6,415,296
-
Value change
-
+$3,553,188
-
Put/Call ratio
-
59.76%
-
Number of buys
-
9
-
Number of sells
-
-4
-
Price
-
$107.43
Significant Holders of DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) as of Q3 2021
29 filings reported holding CURE - DIREXION SHS ETF TR - HEALTHCARE BUL as of Q3 2021.
DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 59,622 shares
.
Largest 10 shareholders include Virtu Financial LLC (14,391 shares), Traynor Capital Management, Inc. (8,258 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (6,759 shares), CITADEL ADVISORS LLC (6,311 shares), FLOW TRADERS U.S. LLC (6,227 shares), Capital Investment Advisors, LLC (3,005 shares), Qube Research & Technologies Ltd (2,977 shares), WOLVERINE TRADING, LLC (2,444 shares), SIMPLEX TRADING, LLC (2,296 shares), and MORGAN STANLEY (1,924 shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.